Welcoming the New Kid on the Block; A Phase IIb Study of DDFPe in Large Vessel Strokes


Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Trial

NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial

Dodecafluoropentane Improves Neurological Function Following Anterior Ischemic Stroke

DDFPe Extends Window for tPA Therapy in a Rabbit Stroke Model

DDFPe delays and reduces MRI markers of infarction in a rat stroke model

Multiple Applications of DDFPe Prevents Death in a Rabbit Stroke Model

A preliminary PET evaluation of DDFPe effects on rabbit brain hypoxia in stroke

DDFPe Decreases Stroke Size and Improves Neurological Scores in a Rat Stroke Model

Progress in Dodecafluoropentane Emulsion as a Neuroprotective Agent in a Rabbit Stroke Model

Dodecafluoropentane Emulsion Decreases Infarct Volume in a Rabbit Ischemic Stroke Model